XML 58 R46.htm IDEA: XBRL DOCUMENT v3.25.1
Research, Collaboration and Licensing Agreements - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Mar. 31, 2025
Jan. 31, 2025
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revenue     $ 27,110 $ 10,030  
Contract assets $ 197   197   $ 100
Contract liabilities 38,102   38,102   40,195
Deferred revenue 23,495   23,495   $ 25,588
GlaxoSmithKline Intellectual Property Development Ltd. (“GSK”): | Milestone revenue          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revenue   $ 14,000 14,000 0  
Daiichi Sankyo, Co., Ltd. (“Daiichi Sankyo”): | Milestone revenue          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revenue $ 3,100   $ 3,100 $ 0